tacrine and chiniofon

tacrine has been researched along with chiniofon in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conde, S; Fernández-Bachiller, MI; García, AG; González-Muñoz, GC; López, MG; Pérez, C; Rodríguez-Franco, MI; Villarroya, M1
Antequera, D; Bolos, M; Carro, E; Fernandez-Bachiller, MI; Ferrer, I; Pascual, C; Rodríguez-Franco, MI; Spuch, C1

Other Studies

2 other study(ies) available for tacrine and chiniofon

ArticleYear
Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
    Journal of medicinal chemistry, 2010, Jul-08, Volume: 53, Issue:13

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Chelating Agents; Cholinesterase Inhibitors; Copper; Humans; Hydroxyquinolines; Magnetic Resonance Spectroscopy; Neuroprotective Agents; Propidium; Spectrometry, Mass, Electrospray Ionization; Tacrine

2010
Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Neurobiology of disease, 2012, Volume: 46, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Cell Death; Cells, Cultured; Hippocampus; Humans; Hydroxyquinolines; Immunohistochemistry; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Presenilin-1; Tacrine

2012